These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 6606528

  • 1. Clinical trials in the rheumatic diseases.
    Clin Rheum Dis; 1983 Dec; 9(3):489-698. PubMed ID: 6606528
    [No Abstract] [Full Text] [Related]

  • 2. [Problems in experimental and clinical trials of antirheumatic agents].
    Trnavský K.
    Cesk Farm; 1983 May; 32(3-4):145-8. PubMed ID: 6347403
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Controlled clinical testing of a new anti-inflammatory agent].
    Malerba F, Barbi GL.
    Clin Ter; 1969 Apr 15; 49(1):63-7. PubMed ID: 4930402
    [No Abstract] [Full Text] [Related]

  • 8. Interpreting clinical trials of antirheumatic drug therapy.
    Bellamy N, Buchanan WW.
    Bull Rheum Dis; 1986 Apr 15; 36(2):1-10. PubMed ID: 3493823
    [No Abstract] [Full Text] [Related]

  • 9. [Principles of clinical testing of drugs used in rheuatology].
    Vrhovac B.
    Reumatizam; 1975 Apr 15; 22(1):3-15. PubMed ID: 1090991
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Experiences with Perclusone in our hospital].
    Pekota J, Kozić S.
    Reumatizam; 1974 Apr 15; 21(4):147-9. PubMed ID: 4605666
    [No Abstract] [Full Text] [Related]

  • 12. Conference on outcome measures in rheumatological clinical trials. Hamilton, Ontario, Canada, December 7-8, 1981.
    J Rheumatol; 1982 Apr 15; 9(5):749-806. PubMed ID: 6983580
    [No Abstract] [Full Text] [Related]

  • 13. [Effectiveness of Voltaren and Brufen in rheumatic diseases].
    Franović A.
    Reumatizam; 1975 Apr 15; 22(3):101-3. PubMed ID: 1096255
    [No Abstract] [Full Text] [Related]

  • 14. [The pharmacotherapy of rheumatoid diseases (3): clinical pharmacological points of view].
    Edström B, Sjöqvist F.
    Lakartidningen; 1969 Oct 13; 66():Suppl 3:56-61. PubMed ID: 4911074
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Pediatric Rheumatology Collaborative Study Group--the first nine years.
    Brewer EJ.
    J Rheumatol; 1982 Oct 13; 9(1):1-2. PubMed ID: 7045357
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical results obtained with a new anti-inflammatory preparation, PIR-353 and indoarginine combination].
    Barceló P, Santamaría A, Obach J, Alabart L.
    Rev Esp Reum Enferm Osteoartic; 1971 Oct 13; 14(3):227-38. PubMed ID: 4940252
    [No Abstract] [Full Text] [Related]

  • 18. [Flufenamic acid. Double-blind clinical tests in repeated series during 2 and one-half years].
    López Prats JL, Valdés M.
    Rev Esp Reum Enferm Osteoartic; 1968 Oct 13; 12(8):215-6. PubMed ID: 4899415
    [No Abstract] [Full Text] [Related]

  • 19. [Bumadizone-calcium in rheumatic diseases. Clinical study].
    Bröll H, Tausch G, Sochor H, Eberl R.
    MMW Munch Med Wochenschr; 1974 Feb 15; 116(15):339-40. PubMed ID: 4209902
    [No Abstract] [Full Text] [Related]

  • 20. [Liver tolerance of niflumic acid during treatment of degenerative rheumatic disease].
    Franke G.
    Ther Ggw; 1972 Dec 15; 111(12):1780 passim. PubMed ID: 4569031
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.